SAN FRANCISCO, CA – (April 8, 2026) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) who purchased or otherwise acquired the securities of ImmunityBio between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”) to
SAN FRANCISCO, CA – (April 9, 2026) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Driven Brands Holdings, Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) who purchased or otherwise acquired the common stock of Driven Brands between May 3, 2023 and February 24, 2026, inclusive (the “Class Period”)
SAN FRANCISCO, CA – (March 18, 2026) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) who purchased or otherwise acquired the publicly traded securities of Kyndryl between August 1, 2024 and February 9, 2026, inclusive (the “Class Period”) to contact
As reported in Bloomberg News (subscription required), New York’s city and state pension funds, along with major institutional investors including the Chicago Teachers’ Pension Fund and Denver Employees Retirement Plan, are urging the U.S. Securities and Exchange Commission (SEC) to reverse a recent policy permitting companies to push shareholder fraud claims into private arbitration.
Lieff Cabraser attorneys Lydia Lee, Katherine Lubin Benson, and Mike Sheen will be speakers at the upcoming NCPERS Annual Conference & Exhibition (ACE), happening May 19-22, 2024, in Seattle, WA. On day three of the conference (5/21), all three attorneys will participate in a panel discussion on “What Makes a Good Securities Case: Essentials for Public
SAN FRANCISCO, CA – (December 21, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in National Instruments Corporation (“National Instruments” or “NATI” or the “Company”) (NASDAQ: NATI) who suffered losses from selling NATI common stock between May 25, 2022 and January 17, 2023 to contact us immediately regarding a
SAN FRANCISCO, CA – (December 14, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG) who suffered losses from purchasing or otherwise acquiring the securities of Dollar General between May 28, 2020 and August 31, 2023 to contact us
SAN FRANCISCO, CA – (December 11, 2023) – National plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) who suffered losses from purchasing or otherwise acquiring FMC common stock between February 9, 2022 and October 30, 2023 to contact us immediately regarding a pending
SAN FRANCISCO, CA – (November 9, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in DocGo Inc. (“DocGo” or the “Company”) (Nasdaq: DCGO) who suffered losses from purchasing or otherwise acquiring the securities of DocGo between November 8, 2022 and September 17, 2023 to contact us immediately regarding a
Corporate fraud is a pervasive issue with far-reaching consequences on individuals, businesses, and the economy as a whole. In the face of financial misconduct, plaintiff lawyers play a critical role in seeking restitution for victims and holding wrongdoers accountable.